IMTXW Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 22:00):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States...

Stats
Tagesvolumen	1 302
Durchschnittsvolumen	0
Marktkapitalisierung	1.26B
EPS	$-0.0311 ( Q1 \| 2024-05-14 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0280 (0.93%)

AADI -2.86%

ABCL -2.15%

ABCM 0.04%

ABEO -2.99%

ABIO 2.29%

ABOS -4.46%

ABSI -3.29%

ABUS -0.65%

ABVX -3.34%

ACAD -1.76%

ACER -17.95%

ACET -2.00%

ACGN 1.29%

ACHL 1.43%

ACHV -1.90%

ACIU -3.37%

ACLX -4.07%

ACRV -3.19%

ACST -3.13%

ACXP -4.82%

ADAG -3.08%

ADAP -1.67%

ADGI 0.87%

ADIL -0.87%

ADMA 0.00%

ADPT 3.04%

ADTX 1.13%

ADVM 1.02%

ADXN -1.60%

AEON 5.94%

AEZS 0.22%

AFMD -3.54%

AGEN -2.36%

AGIO -1.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.20%

AKRO -1.47%

AKTX -25.54%

AKUS 0.00%

ALBO 0.00%

ALDX 1.22%

ALEC -5.01%

ALGS -6.06%

ALKS -1.83%

ALLK -1.67%

ALLO -8.05%

ALLR -34.80%

ALNA 3.16%

ALNY 7.74%

ALPN 0.02%

ALPX 0.00%

ALRN -1.64%

ALT 3.78%

ALVR -1.01%

ALXN 0.00%

ALXO 0.31%

ALZN -2.08%

AMRN 2.72%

AMTI -3.13%

ANAB -0.83%

ANEB 4.87%

ANGN 0.00%

ANIX -1.20%

ANL -3.22%

ANNX -3.98%

ANPC -3.15%

APGE -3.92%

APGN 8.48%

APGNW 30.65%

APLM -3.77%

APLS 5.15%

APLT -4.10%

APM 1.06%

APOP 0.38%

APRE 0.24%

APTO -1.43%

APTX 3.17%

APVO -6.12%

ARAV -13.39%

ARCT -3.88%

ARDS 2.28%

ARDX -3.68%

ARGX 2.49%

ARNA 0.00%

ARPO -0.90%

ARQT 8.11%

ARTL 11.29%

ARTLW 0.00%

ARVN -2.04%

ARWR -1.36%

ASLN -2.08%

ASMB -1.91%

ASND 4.95%

ATAI -3.57%

ATHA -7.59%

ATHE -0.83%

ATHX -33.50%

ATNF -0.66%

ATOS -3.74%

ATRA -6.10%

ATXI -2.72%

ATXS -1.74%

AUPH -1.59%

AURA -4.22%

AUTL -6.45%

AVBP -2.13%

AVEO 0.00%

AVIR -1.72%

AVRO -1.41%

AVTE -3.33%

AVTX 3.46%

AVXL -3.80%

AXLA 0.00%

AXSM 0.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -1.92%

BCDA 3.53%

BCDAW -39.75%

BCEL 0.00%

BCLI 3.13%

BCRX -3.03%

BCTX -13.88%

BCTXW -4.44%

BCYC -2.58%

BDRX -2.01%

BDTX -3.89%

BEAM -2.34%

BFRA -2.91%

BGNE -5.13%

BIOR -2.10%

BIVI -5.32%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -5.71%

BLTE -0.27%

BLU 0.03%

BLUE -7.08%

BMEA -6.13%

BMRN -0.20%

BNOX -9.25%

BNTC 0.00%

BNTX -2.57%

BOLD -18.11%

BOLT 0.18%

BPMC 0.42%

BPTH 0.48%

BPTS -13.47%

BRNS 0.74%

BRTX 2.91%

BTAI -0.84%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -5.22%

CABA -13.47%

CADL -8.13%

CALA 0.00%

CALC 0.00%

CALT -1.18%

CAPR -3.13%

CARA -2.56%

CARM 2.68%

CASI -4.74%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.86%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -8.01%

CDIOW 24.00%

CDMO -1.53%

CDMOP 0.04%

CDT -15.17%

CDTTW -39.60%

CDTX 5.75%

CDXC -4.31%

CDXS -3.33%

CELC -1.02%

CELU -2.60%

CELUW 11.80%

CERC -1.68%

CERE -4.49%

CERO -14.81%

CEROW 0.60%

CFRX -27.95%

CGEM -5.47%

CGEN -3.21%

CGON -1.47%

CGTX -4.86%

CHMA -6.00%

CHRS -3.07%

CINC 0.00%

CING -3.46%

CINGW 34.95%

CKPT 0.48%

CLBS -16.75%

CLDX 0.11%

CLGN 0.59%

CLLS 1.05%

CLNN -5.91%

CLNNW 0.00%

CLRB -5.59%

CLSD 15.74%

CLSN -0.68%

CLVS 0.00%

CMMB 2.45%

CMND -7.46%

CMPI 0.00%

CMPX -4.50%

CMRA 0.00%

CMRAW 33.33%

CMRX 2.05%

CNCE 0.00%

CNSP 27.35%

CNST 0.00%

CNTA 0.00%

CNTB -3.62%

CNTX 0.46%

COCP -7.20%

COEPW 32.45%

COGT -6.41%

CORT -0.65%

COYA 4.24%

CPRX -1.56%

CRBP 1.93%

CRBU -5.88%

CRDF -4.24%

CRGX -4.30%

CRIS -4.39%

CRNX -1.73%

CRSP -3.43%

CRTX 2.63%

CRVO 0.00%

CRVS -2.73%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -9.02%

CTNM 3.86%

CTXR 5.10%

CUE -1.70%

CVAC 2.02%

CVKD -2.39%

CWBR 2.80%

CYAD -12.96%

CYCC -4.79%

CYCCP 5.49%

CYCN 5.02%

CYT -2.27%

CYTK -1.91%

CYTO -6.78%

DARE -2.35%

DAWN -0.96%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 1.80%

DNLI -2.27%

DNTH -5.02%

DOMH 2.16%

DRMA -6.21%

DRMAW -1.25%

DRNA 0.00%

DRTS -1.82%

DRTSW 0.00%

DRUG 5.61%

DSGN -1.49%

DTIL 0.95%

DYAI -3.13%

EARS -1.77%

EDIT -2.17%

EDSA -3.71%

EFTR -1.06%

EFTRW 145.45%

EIGR -9.21%

ELAB -1.03%

ELDN -8.81%

ELEV -1.63%

ELOX -7.14%

ELTX -4.76%

ELVN -1.69%

ELYM -5.28%

ENGN -0.37%

ENGNW 18.81%

ENLV -3.55%

ENOB 1.79%

ENSC -3.98%

ENTA 0.25%

ENTO 1.69%

ENTX -9.22%

ENVB -7.29%

EPIX 0.00%

EPRX -2.97%

EPZM 0.00%

EQ 0.46%

EQRX -2.09%

EQRXW 0.00%

ERAS -3.70%

ERNA -1.64%

ERYP 1.30%

ESLA -0.65%

ESLAW 87.05%

ETNB -6.98%

ETON -1.20%

ETTX 0.00%

EVAX 6.44%

EVGN 0.58%

EVLO 0.00%

EWTX 4.07%

EXAI 0.95%

EXEL -0.27%

EYEG 0.04%

EYEN -2.23%

EYPT -3.05%

FATE -3.13%

FBIO -0.59%

FBIOP 0.32%

FBLG 0.00%

FBRX -6.12%

FDMT -5.38%

FENC -2.36%

FGEN -2.50%

FHTX -1.50%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.30%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -2.26%

FULC -5.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 4.69%

GANX 0.78%

GBIO 1.43%

GBT 0.01%

GDTC -1.45%

GERN -1.53%

GHRS 0.84%

GLMD -2.79%

GLPG -2.10%

GLSI -0.77%

GLTO -6.44%

GLUE -0.52%

GLYC 25.28%

GMAB -0.15%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.81%

GNLX -0.88%

GNPX 0.99%

GNTA 3.94%

GOSS 22.26%

GOVX -27.39%

GOVXW -49.04%

GPCR -8.52%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.41%

GRTX 12.03%

GTHX -0.90%

GUTS -9.22%

GXGXW 41.67%

GYRE -3.78%

HALO 0.65%

HARP 0.09%

HCWB -1.65%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -2.68%

HOOK 0.30%

HOTH -4.46%

HOWL -10.34%

HRMY -0.07%

HRTX -4.09%

HSTO 0.00%

HUMA -3.33%

HUMAW 1.27%

IBRX -0.95%

ICCC 0.22%

ICPT 0.21%

ICU -19.90%

ICUCW -13.76%

ICVX -0.91%

IDRA -23.04%

IDYA -2.38%

IFRX -2.99%

IGMS -6.44%

IKNA 0.00%

IKT 0.40%

IMAB 0.00%

IMCR -1.09%

IMGN 0.02%

IMGO 0.00%

IMMP -1.13%

IMMX 1.75%

IMNM -3.35%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -4.03%

IMTX -1.64%

IMTXW 6.00%

IMUX -1.82%

IMV 0.00%

IMVT -0.29%

INAB 1.54%

INBX -2.46%

INCY -1.02%

INDP -1.80%

INFI -52.38%

INKT -1.11%

INM -6.35%

INMB -5.05%

INO -3.39%

INSM 1.87%

INTS 0.20%

INVA 0.88%

INZY -2.46%

IOBT 6.72%

IONS 5.19%

IOVA 3.55%

IPA 0.00%

IPHA -1.72%

IPSC -4.48%

IRON -1.04%

ISEE 0.38%

ITOS -1.81%

ITRM 3.42%

IVA 6.96%

IVVD -4.72%

JAGX 0.53%

JANX -4.05%

JAZZ -1.59%

JNCE 0.00%

JSPR -5.33%

JSPRW -16.18%

JUNS 0.00%

JUNSW 0.00%

KA -13.66%

KALV -1.45%

KDNY 0.22%

KMPH -0.34%

KNSA 0.53%

KNTE -0.38%

KOD -7.33%

KPRX 2.21%

KPTI -0.91%

KRBP -10.00%

KRON -6.43%

KROS -1.79%

KRRO -4.81%

KRTX 0.03%

KRYS 1.37%

KTRA 13.76%

KTTA 8.16%

KTTAW 0.92%

KURA -2.80%

KYMR -0.95%

KYTX -1.90%

KZIA -12.30%

KZR 0.97%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.00%

LENZ -2.43%

LEXX -2.26%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -2.08%

LIAN -8.28%

LIFE 2.70%

LIPO -23.38%

LIXT 0.77%

LIXTW -42.57%

LJPC -0.32%

LMNL 0.12%

LOGC 2.68%

LPCN -12.37%

LPTX -3.19%

LQDA -2.54%

LRMR -3.50%

LSTA 3.21%

LTRN 2.56%

LUMO -1.32%

LVTX 3.19%

LXEO -0.76%

LXRX -6.08%

LYEL -3.77%

LYRA -1.79%

MACK 0.10%

MBIO -12.31%

MBRX -0.71%

MCRB -1.11%

MDGL -1.39%

MDNA -13.16%

MDWD 0.55%

MDXG -0.15%

MEIP 2.88%

MESO -0.59%

MGNX -4.67%

MGTA -7.74%

MGTX -1.17%

MGX 3.61%

MIRM -4.91%

MIRO 0.59%

MIST -7.19%

MITO 0.00%

MLEC 7.41%

MLECW 23.81%

MLND -5.36%

MLTX 2.56%

MLYS -3.64%

MNKD -3.50%

MNMD -4.20%

MNOV 2.16%

MNPR 2.63%

MOLN 0.97%

MOR -1.71%

MORF 6.79%

MREO -6.91%

MRKR -1.49%

MRNA 0.44%

MRNS -0.73%

MRSN -4.98%

MRTX -0.17%

MRUS -0.23%

MRVI -2.83%

MTCR -1.29%

MTEM -2.88%

MTP -18.50%

MURA 0.31%

MYMD -1.60%

NAMS 0.20%

NAMSW 0.43%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 11.93%

NCNA -5.00%

NERV -2.15%

NEXI -1.06%

NGM -1.28%

NGNE -2.05%

NKGN 0.00%

NKGNW 8.00%

NKTR -8.55%

NKTX 9.46%

NLSP -7.12%

NLSPW 26.67%

NMRA -7.89%

NMTR -42.97%

NOVN -24.84%

NRBO 4.41%

NRIX -1.09%

NRSN 1.06%

NRSNW 0.00%

NRXP 0.75%

NRXPW 27.78%

NRXS -2.73%

NTBL -11.13%

NTEC -12.45%

NTHI 0.00%

NTLA -4.00%

NTRBW -31.07%

NUVL -0.30%

NVAX -0.14%

NVCT -1.39%

NVIV -34.28%

NXTC 1.19%

NYMX -0.05%

OABI -6.65%

OABIW -10.06%

OBIO -0.58%

OBSV 0.00%

OCEA 2.16%

OCGN -6.35%

OCS -0.30%

OCUL 0.46%

OCUP -4.38%

ODT -4.27%

OKYO -4.13%

OLMA -1.26%

OMER -4.77%

OMGA -0.83%

ONCO -2.22%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO -5.06%

OPNT 0.00%

OPT -1.03%

ORGS -1.66%

ORIC -5.73%

ORMP 0.45%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.10%

OVID -11.39%

OYST 0.00%

PALI -3.25%

PASG 0.22%

PBLA 0.00%

PBM -4.22%

PBYI 1.37%

PCSA 6.92%

PCVX -1.69%

PDSB 10.49%

PEPG -6.00%

PGEN 3.73%

PHAR -6.99%

PHAS 0.00%

PHAT -4.62%

PHIO 2.30%

PHIOW 36.47%

PHVS 7.54%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.79%

PLUR -5.45%

PMN -5.66%

PMVP -0.59%

PNT 0.16%

PPBT -7.68%

PRAX -6.28%

PRDS 0.93%

PRLD -3.56%

PROG -3.47%

PROK -3.46%

PRQR 0.61%

PRTA -3.84%

PRTC -0.08%

PRTG -5.03%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 1.86%

PSTX -6.18%

PTCT -1.73%

PTE -0.82%

PTGX -0.94%

PTIXW -5.10%

PULM 2.63%

PXMD -4.59%

PYPD 0.07%

PYXS -4.08%

QLGN -6.58%

QNCX -2.48%

QNRX -4.84%

QSI -2.50%

QSIAW -3.13%

QTTB -3.97%

QURE -1.76%

RAIN -1.63%

RANI -9.00%

RAPT -4.94%

RARE 1.09%

RCKT -0.87%

REGN 0.69%

RENB 1.26%

REPL 0.68%

RETA 0.02%

REUN -0.89%

REVB -10.42%

REVBU 3.46%

REVBW -38.46%

RGLS 4.39%

RGNX -3.67%

RIGL -11.87%

RLAY -2.32%

RLMD -0.33%

RLYB -3.25%

RNA -1.79%

RNAC 4.43%

RNAZ 1.96%

RNXT -1.74%

ROIV -0.73%

ROIVW 4.56%

RPHM -0.62%

RPRX -0.77%

RPTX -3.67%

RUBY 2.70%

RVLP -32.05%

RVMD 0.86%

RVMDW 5.10%

RVNC -8.56%

RVPH -1.56%

RVPHW -3.43%

RXDX 0.09%

RXRX 0.43%

RYTM 0.52%

RYZB 0.02%

RZLT -9.15%

SABS 0.00%

SABSW 0.25%

SAGE -5.71%

SANA -2.17%

SAVA -2.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.04%

SCPH -2.94%

SCPS 0.00%

SEEL 2.13%

SEER -1.73%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.94%

SGMT -1.43%

SGTX -2.56%

SIOX 22.63%

SLDB -12.39%

SLGL 8.36%

SLN -2.01%

SLNO -2.84%

SLRX 1.24%

SLS -3.31%

SMMT 0.13%

SNDX -1.31%

SNGX -21.60%

SNPX -3.13%

SONN -0.33%

SPPI -0.49%

SPRB 3.68%

SPRC -2.37%

SPRO 0.00%

SRNE -9.09%

SRPT -3.53%

SRRA 0.00%

SRRK -4.04%

SRZN -2.45%

STAB 0.00%

STOK -2.65%

STRO -2.61%

STSA 0.00%

STTK -10.11%

SURF -0.93%

SVRA 3.83%

SWTX 0.94%

SYBX 1.97%

SYRS -0.17%

TALS -0.73%

TARA -5.83%

TARS -2.36%

TBPH -4.22%

TCBP -9.85%

TCDA 0.00%

TCON 21.14%

TCRR 0.00%

TCRT -3.63%

TCRX -7.47%

TECH -1.91%

TENX 3.88%

TERN -3.59%

TFFP 3.68%

TGTX 4.24%

THRX 0.12%

TIL 0.00%

TLC 0.00%

TLSA 2.32%

TNGX -8.77%

TNXP 5.04%

TNYA -7.61%

TPST -1.44%

TRDA 3.72%

TRVI -1.14%

TRVN -2.41%

TSHA -7.33%

TSVT -2.59%

TTNP -0.91%

TVTX 2.18%

TYRA -0.88%

UBX 0.36%

UNCY -26.76%

URGN -5.61%

UTHR 0.03%

VACC 11.36%

VALN -4.35%

VAXX -5.88%

VBIV 3.23%

VBLT -8.77%

VCEL -2.81%

VCNX -6.47%

VCYT -0.92%

VERA 0.97%

VERU -6.67%

VERV -0.95%

VIGL -4.12%

VINC -3.01%

VIR 0.66%

VIRI -5.96%

VIRX -3.22%

VKTX -8.29%

VLON -13.04%

VNDA 2.68%

VOR 0.00%

VRCA -0.98%

VRDN -3.41%

VRNA -4.14%

VRPX -2.58%

VRTX -0.24%

VSTM -5.16%

VTGN 2.79%

VTVT -6.43%

VTYX -4.02%

VXRT -7.63%

VYGR -2.92%

VYNE 0.00%

VYNT 7.78%

WINT -3.24%

WVE -8.45%

XBIO -8.15%

XBIT 5.73%

XCUR -4.08%

XENE -1.10%

XERS -0.47%

XFOR -4.95%

XLO -3.30%

XLRN 0.00%

XNCR -3.68%

XOMA -5.07%

XOMAO 0.36%

XOMAP 0.73%

XRTX -3.29%

YMAB 1.16%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.23%

ZNTL -8.70%

ZSAN 0.00%

Korrelation (AI algo v.1.1b): Undervalued: 0.07% $3.00 paired level. (Der Algorithmus verfolgt in Echtzeit die Änderungen der am stärksten korrelierten Aktien und gibt eine sofortige Aktualisierung)

immatics biotechnologies Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

immatics biotechnologies Finanzdaten

Annual	2023
Umsatz:	$54.00M
Bruttogewinn:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2023
Umsatz:	$54.00M
Bruttogewinn:	$-64.67M (-119.76 %)
EPS:	$-1.200

FY	2022
Umsatz:	$172.83M
Bruttogewinn:	$66.05M (38.22 %)
EPS:	$0.550

Financial Reports:

No articles found.

immatics biotechnologies Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

immatics biotechnologies

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.